2026 NPPES data Hematology & Oncology Physician NPI 1275608077 M.D.
Verify on CMS →

REGINA MELINK, M.D.

Hematology & Oncology Physician in HILLSBORO, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
126
Medicare Part D claims · 42 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: REGINA MELINK, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in HILLSBORO, Ohio with a Medicare Part D prescribing footprint of 126 claims across 42 beneficiaries — 24% brand-name prescribing .

What stands out: REGINA MELINK, M.D. filed 126 Medicare Part D claims in 2023 across HILLSBORO, Ohio. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

REGINA MELINK, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

REGINA MELINK, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 11/21/2006

NPI 1275608077

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

126 85% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Ohio

How Hematology & Oncology Physician compares to other specialties among Ohio providers

Ohio providers

Hematology & Oncology Physician share within Ohio

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Ohio

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

REGINA MELINK, M.D. is a Hematology & Oncology Physician provider practicing in HILLSBORO, Ohio, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1275608077. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

REGINA MELINK, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 1275 N HIGH ST, HILLSBORO, OH, 45133, with a listed phone of (937) 393-6100. NPI 1275608077 was issued on 11/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MELINK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 126 prescription claims written by this provider, covering 42 Medicare beneficiaries and totaling roughly $471K in drug spend, split 24% brand-name and 76% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1275 N HIGH ST
HILLSBORO, OH 45133

Provider Details

NPI 1275608077
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 11/21/2006

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to REGINA MELINK, M.D.. To verify REGINA MELINK, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

REGINA MELINK, M.D. — brand share 24.0%
Specialty average (est.)

24% brand-name claims vs 76% generic, on 126 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

126
Total Claims
$471K
Total Drug Cost
42
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
204
Total Day Supply
5,931
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$401K
Generic Drug Cost
$70K

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
2.39
Gender Split
69% female / 31% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
35

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How REGINA MELINK, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

REGINA MELINK, M.D.'s 126 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as MELINK.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is REGINA MELINK, M.D.'s specialty?
REGINA MELINK, M.D. specializes in Hematology & Oncology Physician and practices in HILLSBORO, Ohio. Credentials: M.D..
How much does REGINA MELINK, M.D. prescribe under Medicare Part D?
In 2023, REGINA MELINK, M.D. wrote 126 Medicare Part D claims totaling $471K in drug costs for 42 beneficiaries.
Where is REGINA MELINK, M.D. located?
REGINA MELINK, M.D. is located at 1275 N HIGH ST, HILLSBORO, OH, 45133. Phone: (937) 393-6100.
What is REGINA MELINK, M.D.'s NPI number?
REGINA MELINK, M.D.'s National Provider Identifier (NPI) is 1275608077, issued on 11/21/2006.
Does REGINA MELINK, M.D. prescribe more brand-name or generic drugs?
REGINA MELINK, M.D.'s prescribing is 24% brand-name and 76% generic drugs by claim count, with $401K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does REGINA MELINK, M.D. prescribe most often?
Based on 2023 Medicare Part D data, REGINA MELINK, M.D.'s most frequently prescribed drugs include Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does REGINA MELINK, M.D. accept Medicare?
REGINA MELINK, M.D. appears in CMS Medicare data with 126 Part D claims and 42 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify REGINA MELINK, M.D.'s credentials?
REGINA MELINK, M.D.'s NPI is 1275608077 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology